- Stocks
- Healthcare
- NYSE: CRY

Price (delayed)

$29.58

Market cap

$1.16B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.35

Enterprise value

$1.45B

CRY's EPS is up by 20% since the previous quarter

The net income has plunged by 183% YoY but it has grown by 21% from the previous quarter

CRY's equity is down by 10% since the previous quarter but it is up by 7% year-on-year

The debt has grown by 31% YoY and by 13% from the previous quarter

CRY's quick ratio is down by 30% year-on-year

What are the main financial stats of CRY

Market
Valuations
Earnings

Shares outstanding

39.1M

Market cap

$1.16B

Enterprise value

$1.45B

Price to earnings (P/E)

N/A

Price to book (P/B)

3.88

Price to sales (P/S)

4.44

EV/EBIT

380.89

EV/EBITDA

42.02

EV/Sales

5.63

Revenue

$257.89M

EBIT

$3.81M

EBITDA

$34.53M

Free cash flow

$404,000

Per share
Balance sheet
Liquidity

EPS

-$0.35

Free cash flow per share

$0.01

Book value per share

$7.63

Revenue per share

$6.66

TBVPS

$8.33

Total assets

$794.83M

Total liabilities

$497.5M

Debt

$351.22M

Equity

$297.33M

Working capital

$177.67M

Debt to equity

1.18

Current ratio

4.06

Quick ratio

1.86

Net debt/EBITDA

8.53

Margins
Efficiency
Dividend

EBITDA margin

13.4%

Gross margin

66.5%

Net margin

-5.1%

Operating margin

2%

Return on assets

-1.7%

Return on equity

-4.2%

Return on invested capital

0.7%

Return on capital employed

0.5%

Return on sales

1.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Cryolife stock price performed over time

Intraday

0%

1 week

2.82%

1 month

2.04%

1 year

25.93%

YTD

25.29%

QTD

31%

How have Cryolife's revenue and profit performed over time

Revenue

$257.89M

Gross profit

$171.45M

Operating income

$5.07M

Net income

-$13.16M

Gross margin

66.5%

Net margin

-5.1%

The net margin has plunged by 200% YoY but it has grown by 23% from the previous quarter

The net income has plunged by 183% YoY but it has grown by 21% from the previous quarter

The operating income has soared by 108% QoQ but it has shrunk by 63% YoY

Cryolife's operating margin has surged by 100% QoQ but it has shrunk by 60% YoY

What is Cryolife's growth rate over time

What is Cryolife stock price valuation

P/E

N/A

P/B

3.88

P/S

4.44

EV/EBIT

380.89

EV/EBITDA

42.02

EV/Sales

5.63

CRY's EPS is up by 20% since the previous quarter

CRY's P/B is 49% more than its last 4 quarters average of 2.6 and 25% more than its 5-year quarterly average of 3.1

CRY's equity is down by 10% since the previous quarter but it is up by 7% year-on-year

CRY's P/S is 43% higher than its last 4 quarters average of 3.1 and 27% higher than its 5-year quarterly average of 3.5

The revenue fell by 6% YoY

How efficient is Cryolife business performance

Cryolife's return on equity has shrunk by 147% YoY but it has increased by 22% QoQ

The ROA has dropped by 113% year-on-year but it has increased by 26% since the previous quarter

The ROIC has dropped by 68% year-on-year

CRY's ROS has dropped by 57% year-on-year

What is CRY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CRY.

How did Cryolife financials performed over time

The total assets is 60% more than the total liabilities

Cryolife's total liabilities has increased by 44% YoY and by 8% QoQ

CRY's quick ratio is down by 30% year-on-year

The debt is 18% more than the equity

The debt has grown by 31% YoY and by 13% from the previous quarter

The debt to equity has grown by 24% from the previous quarter and by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.